Gliapharm Sa And The Wyss Center Enter Collaboration To Develop New Therapies For Alzheimers Disease
Gliapharm Sa, A Biotech Company That Specializes In The Research And Development Of Novel Therapies To Treat And Prevent Neurological Diseases, And The Wyss Center, A Non-Profit Organization Dedicated To Accelerating Discoveries In Neuroscience To Improve Patient Lives, Today Announced A Collaboration To Develop New Treatments For Alzheimer'S Disease.One Of The Hallmarks Of Neurodegenerative Diseases Such As Alzheimer
Let’s apply Data-Driven Pricing to Your APIs
Sick and tired of always wondering if you are being asked to pay the right price for your APIs? This empowers you with the answers you need to make the right decisions in the Global API market.
Chemxpert Database is one of the biggest and most comprehensive directories of pharma and chemicals, manufacturers, suppliers and information. Provided with current information on prices, demand and transactions, it gives you instant feedback on whether you are buying what is right and at the right time.
Start using market intelligence today and allow yourself to be in control in the API market.
Check it out today and make more informed sourcing decisions!
Learn More!